Focus on Cedric Francois, MD, PhD, CEO, Apellis Pharmaceuticals
Retina Synthesis - A podcast by Retina Synthesis
Categories:
Dr. Francois discusses the epidemiology of geographic atrophy, the pathophysiology of complement inhibition in the treatment of GA, and the latest information on Apellis' Phase 2 and Phase 3 clinical trials.
